A federal jury in Newark, N.J., has found, after a 14-day trial, that three generic drugmakers infringed Pfizer Inc.'s patent on its acid-reflux drug Protonix. The jury found that Teva Pharmaceuticals USA, Kudco Ireland and Sun Pharma Global infringed on the patent when they filed applications with the Food and Drug Administration to sell generic versions of Protonix. The patent is held by Nycomed of Switzerland. Pfizer said it will seek treble damages for its lost profits.
April 28, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal jury in Newark, N.J., has found, after a 14-day trial, that three generic drugmakers infringed Pfizer Inc.’s patent on its acid-reflux drug, Protonix.
The jury found on April 23 that Teva Pharmaceuticals USA Inc., Kudco Ireland Ltd. and Sun Pharma Global Inc. infringed on the patent when they filed applications with the Food and Drug Administration to sell generic versions of Protonix.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
